Neutra Corp. (NTRR) stock
NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31
Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Neutra revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Neutra's revenue for the twelve months ending Oct 31, 2023 was $17.40K, down 82.7% year over year. For fiscal 2023 it was $68.00K, down 26.1% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Jan 31, 2023 | $68.00K | -26.1% |
| FY2022 | Jan 31, 2022 | $92.01K | +849.9% |
| FY2021 | Jan 31, 2021 | $9.69K | +51.5% |
| FY2020 | Jan 31, 2020 | $6.40K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | $1.31K | -94.4% |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | $4.33K | -85.1% |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | $5.84K | -39.5% |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | $5.92K | -84.6% |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | $23.38K | -11.0% |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | $29.03K | +83.7% |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | $9.66K | -16.4% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | $38.38K | +1629.0% |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | $26.27K | +3518.6% |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | $15.81K | +326.6% |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | $11.55K | +280.5% |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | $2.22K | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | $726 | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | $3.71K | +84.7% |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | $3.04K | – |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | $0 | – |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | $0 | – |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | $2.01K | – |
See a number that looks wrong?